CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.35
-0.11 (-4.47%)
▼
5d:
+4.44%
30d:
-19.24%
90d:
-10.31%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.1% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.1% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.31
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$1.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.35, which is considered fair relative to its 30-day fair value range of $2.15 to $2.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.0) compared to its historical average (12.2). Remarkably, the market is currently pricing in an annual earnings decline of 13.1% over the next few years. This pessimistic expectation contrasts with the company's recent 5739.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.14, while resistance sits at $2.54. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CCLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+160.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.14, while resistance sits at $2.54. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CCLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+160.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.15 -
$2.87
Company Quality Score
53/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
76.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 34th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 160.6% below Wall St target ($6.12)
Trading Range Analysis
30-Day Trading Range
$2.15 -
$2.87
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.26
(11.1%)
Support & Resistance Levels
Support Level
$2.14
Resistance Level
$2.54
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.01
Wall Street Target
$6.13
(+160.6%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
5739.0%
Profit Margin
7.9%
Valuation Discount vs History
-13.1% cheaper
PE vs Historical
8.0 vs 12.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.1%
(market-implied from PE analysis)
1-Year Target
$2.12
(-10%)
2-Year Target
$1.90
(-19%)
3-Year Target
$1.71
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→12)
$2.61
(+11%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -20.0%)
$4.68
(+99%)
Base:
(SPY PE: 8.0, Growth: -20.0%)
$1.71
(-27%)
Bear:
(PE: 6.8, Growth: -20.0%)
$1.46
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 17.31 | Current EPS (TTM): $0.13
Bull Case
$4.95
(+113%)
Analyst growth 100.0%, PE expands to 19.0
Base Case
$4.50
(+94%)
Market implied 100.0%, PE stable at 17.3
Bear Case
$1.53
(-34%)
Severe decline -20.0%, PE contracts to 14.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.0 to 12.2
Stabilization Target:
$3.58
(+52.3%)
PE Expansion Potential:
+52.3%
Share & Embed Analysis
Last updated: June 04, 2026 4:11 AM ET
Data refreshes hourly during market hours. Next update: 5:11 AM
Data refreshes hourly during market hours. Next update: 5:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$263 | 62 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 55 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$113 | 60 BUY |
